Compare Arbitrum (ARB) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arbitrum vs Enzyme — how do they compare? Arbitrum trades at Rp1,347 (market cap Rp8,89T, Rp759,1M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Arbitrum is far larger — about 66279× Enzyme's market cap, and Arbitrum's circulating supply is 6,6B ARB versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 63 Days and Enzyme for 29 Days on average.
| ARB | MLN | |
|---|---|---|
Market Cap | Rp8,89T | Rp134,13M |
Volume (24h) | Rp759,1M | Rp104,56M |
Circulating Supply | 6,6B ARB | 3,3M MLN |
Typical Hold Time | 63 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum (ARB) is currently trading at Rp1,345 with a bearish technical outlook, showing selling pressure across moving averages while oscillators remain neutral. The token faces resistance at Rp1,370 with support at Rp1,321, indicating potential for further downside. Recent ecosystem news includes Pheasant Network's $2M funding round with Ethereum Foundation support to advance AI-powered cross-chain technology.
Overall outlook remains cautious with bearish momentum dominating. Key opportunities lie in ecosystem growth through AI integration, while major risks include technical selling pressure and crypto market volatility. Investors should monitor support levels closely for potential entry points.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
